Sort
53,477 grants matching “addiction”
Inhibiting oncogenic KRAS for cancer therapy
$392,486Garth Powis · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2014 · CA
Selective Opioid Antagonists as Medications for Drug Abuse
$392,440Frank I Carroll · Research Triangle Institute · R01 · FY2012 · DA
Drug Treatment for Transplant Candidates
$392,434St. Luke'S-Roosevelt Inst For Hlth Scis · R01 · FY2003 · DA
Design of Molecular Probes For Optical Imaging of Dopamine Neurotransmission
$392,425Dalibor Sames · Columbia Univ New York Morningside · R01 · FY2010 · MH
Imaging Nicotinic & GABAergic Markers in Tobacco Smokers
$392,422Julie K Staley · Yale University · P50 · FY2008 · AA
Role of prelimbic cortical endocannabinoid signaling in enhanced cocaine-seeking behavior following combined repeated stress and cocaine use in rats
$392,421Jayme Rose McReynolds · University Of Cincinnati · R37 · FY2025 · DA
In vivo chemical monitoring using capillary separations
$392,392Robert T Kennedy · University Of Michigan At Ann Arbor · R37 · FY2011 · EB
UNDERSTANDING NO SIGNALING RESULTING IN NEUROPROTECTION.
$392,392Ted M. Dawson · Johns Hopkins University · P50 · FY2008 · DA
Training Grant on Genetic Aspects of Alcoholism
$392,371William Joseph McBride · Indiana University Indianapolis · T32 · FY2012 · AA
BIOCHEMICAL STUDIES OF OPIATE EFFECACIES
$392,349Sri International · R01 · FY2001 · DA
Selective Opioid Antagonists as Medications for Drug Abuse
$392,337Frank I Carroll · Research Triangle Institute · R01 · FY2011 · DA
C-DIAS RP3: Scaling-out app-based treatments: a multi-level strategy to promote equity across primary care patients with substance use
$392,288Joseph Edwin Glass · Stanford University · P50 · FY2023 · DA
Neural mechanisms mediating appetitive regulation and smoking in nicotine addiction
$392,281Brett Froeliger · University Of Missouri-Columbia · R01 · FY2023 · DA
Neural Mechanisms of Propensity for Drug Taking
$392,263Jill B Becker · University Of Michigan At Ann Arbor · R01 · FY2018 · DA
A Pilot Implementation Project of Methadone and Suboxone for Injecting Drug Users
$392,239Charles P O'Brien · University Of Pennsylvania · R01 · FY2013 · DA
IV Pulsed-Nicotine as a Model of Smoking: The Effects of Dose and Delivery Rate
$392,233Mehmet Sofuoglu · Yale University · R01 · FY2021 · DA
IV Pulsed-Nicotine as a Model of Smoking: The Effects of Dose and Delivery Rate
$392,233Mehmet Sofuoglu · Yale University · R01 · FY2023 · DA
IV Pulsed-Nicotine as a Model of Smoking: The Effects of Dose and Delivery Rate
$392,233Mehmet Sofuoglu · Yale University · R01 · FY2022 · DA
Using Novel Labeling to Improve Public Understanding of Nicotine in Electronic Nicotine Delivery Systems (ENDS): Nicotine Concentration and Nicotine Flux
$392,209Meghan E Morean · Yale University · R01 · FY2024 · DA
C-DIAS RP3: Scaling-out app-based treatments: a multi-level strategy to promote equity across primary care patients with substance use
$392,199Joseph Edwin Glass · Stanford University · P50 · FY2024 · DA
Project 2: The Role of Risk and Benefit Perceptions in Tobacco Control p194-230
$392,164Bonnie L Halpern-Felsher · University Of California, San Francisco · P50 · FY2014 · CA
Behavioral Economic Methods for Assessing Tobacco Product Abuse Liability
$392,149Warren K Bickel · University Of Minnesota · U19 · FY2014 · CA
Treatment Response & Psychophysiology in Preschool ADHD
$392,146Carolyn H Webster-Stratton · University Of Washington · R01 · FY2008 · MH
Integrative Training in the Neurobiology of Addictive Behaviors
$392,144Harriet De Wit · University Of Chicago · T32 · FY2017 · DA
Opioid Receptor Polymorphisms and Nonhuman Primate Models of Alcohol Abuse
$392,113Donna M. Platt · Harvard Medical School · R01 · FY2012 · AA